U.S. launches investigation of drug prices
The Senate's Special Committee on Aging also requested information from Retrophin and Rodelis Therapeutics, according to a statement from the panel's Republican Chairwoman Susan Collins and Claire McCaskill, its top Democrat.
Democratic members of a U.S. House of Representatives investigative committee asked Republicans to call a vote to subpoena Valeant and Turing.
Democratic leaders began calling for investigation of drug prices in September, emboldened by press reports of a more than 5000 percent overnight increase in a toxoplasmosis drug made by Turing and a more than 600 percent increase in a blood pressure treatment from Valeant.
Drugmakers and their defenders say drugs are priced to help enable discovery and development of innovative new treatments. ■